{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:29:58Z","timestamp":1786368598282,"version":"build-2736575974"},"reference-count":391,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"abstract":"<jats:p>ABSTRACT  Background: Helicobacter pylori infection remains highly prevalent, affecting approximately 40% of the global population. Individuals with infection continue to be at risk for its various clinical consequences, including chronic gastritis, peptic ulcer disease, and gastric cancer.  Objective: The Brazilian Helicobacter pylori and Microbiota Study Group and the Brazilian Federation of Gastroenterology present the Fifth Brazilian Consensus on this topic, following the inaugural edition in 1995. Significant advances across various areas have emerged since the publication of the last consensus in 2018. These advances are particularly relevant to bacterial eradication, as treatment encounters mounting challenges due to rising antimicrobial resistance.  Methods: For this update, five working groups were established to address: 1) epidemiology; 2) associated diseases and treatment indications; 3) diagnosis; 4) gastric cancer; and 5) treatment and microbiota.  Conclusion: The groups developed 34 evidence-based recommendations to guide clinicians in managing this infection within the Brazilian population.<\/jats:p>","DOI":"10.1590\/s0004-2803.24612026-043","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:46:33Z","timestamp":1786365993000},"source":"Crossref","is-referenced-by-count":0,"title":["VTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION"],"prefix":"10.1590","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8721-7696","authenticated-orcid":false,"given":"Luiz Gonzaga Vaz","family":"COELHO","sequence":"first","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0193-6292","authenticated-orcid":false,"given":"Bruno Squ\u00e1rcio Fernandes","family":"SANCHES","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-0974","authenticated-orcid":false,"given":"Ismael","family":"MAGUILNIK","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4563-3795","authenticated-orcid":false,"given":"James Ramalho","family":"MARINHO","sequence":"additional","affiliation":[{"name":"Universidade Estadual de Ci\u00eancias da Sa\u00fade de Alagoas,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9081-1522","authenticated-orcid":false,"given":"Sandro Rodrigues","family":"CHAVES","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil; Rede Mater Dei de Sa\u00fade,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3852-1907","authenticated-orcid":false,"given":"Ana Fl\u00e1via P.","family":"RAMOS","sequence":"additional","affiliation":[{"name":"Santa Casa de Belo Horizonte,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0315-4668","authenticated-orcid":false,"given":"Heinrich","family":"SEIDLER","sequence":"additional","affiliation":[{"name":"Universidade Cat\u00f3lica de Bras\u00edlia,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1910-119X","authenticated-orcid":false,"given":"Ricardo C.","family":"BARBUTI","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8956-7879","authenticated-orcid":false,"given":"Renato S.","family":"LABOISSI\u00c8RE","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1748-3622","authenticated-orcid":false,"given":"La\u00e9rcio Ten\u00f3rio","family":"RIBEIRO","sequence":"additional","affiliation":[{"name":"Hospital Universit\u00e1rio Prof. Alberto Antunes,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5247-9477","authenticated-orcid":false,"given":"Maria do Carmo F.","family":"PASSOS","sequence":"additional","affiliation":[{"name":"Santa Casa de Belo Horizonte,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8117-6643","authenticated-orcid":false,"given":"Julio C\u00e9sar de Soares","family":"VELOSO","sequence":"additional","affiliation":[{"name":"Hospital Santa Helena,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8258-4684","authenticated-orcid":false,"given":"Lucia Liban\u00eas C.","family":"BRAGA","sequence":"additional","affiliation":[{"name":"Universidade Federal do Cear\u00e1,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-3506","authenticated-orcid":false,"given":"Frederico Passos","family":"MARINHO","sequence":"additional","affiliation":[{"name":"Universidade Federal de Minas Gerais,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1902-3575","authenticated-orcid":false,"given":"Helenice P.","family":"BREYER","sequence":"additional","affiliation":[{"name":"Universidade Federal do Rio Grande do Sul,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9911-6582","authenticated-orcid":false,"given":"Hoiti","family":"OKAMOTO","sequence":"additional","affiliation":[{"name":"Centro M\u00e9dico Oxford,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2365-8758","authenticated-orcid":false,"given":"Jardel Soares","family":"CAETANO","sequence":"additional","affiliation":[{"name":"Hospital C\u00e1rdio Pulmonar (Rede D\u2019Or S\u00e3o Luiz),  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-8445","authenticated-orcid":false,"given":"Paulo Pimentel","family":"D\u2019ASSUMP\u00c7\u00c3O","sequence":"additional","affiliation":[{"name":"Universidade Federal do Par\u00e1,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7258-2654","authenticated-orcid":false,"given":"Leonardo Soares da","family":"SILVA","sequence":"additional","affiliation":[{"name":"Hospital Adventista de Manaus,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0431-451X","authenticated-orcid":false,"given":"Gerson","family":"DOMINGUES","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6346-3967","authenticated-orcid":false,"given":"Raul Carlos","family":"WAHLE","sequence":"additional","affiliation":[{"name":"Universidade Federal de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1181-3616","authenticated-orcid":false,"given":"Eliza Maria de","family":"BRITO","sequence":"additional","affiliation":[{"name":"Universidade Professor Edson Ant\u00f4nio Vellano,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2239-7358","authenticated-orcid":false,"given":"Marcela Tavares da Rocha","family":"LOURES","sequence":"additional","affiliation":[{"name":"Hospital Nossa Senhora das Gra\u00e7as,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-6047","authenticated-orcid":false,"given":"Joaquim Prado","family":"MORAES-FILHO","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-6687","authenticated-orcid":false,"given":"D\u00e9cio","family":"CHINZON","sequence":"additional","affiliation":[{"name":"Universidade de S\u00e3o Paulo,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4145-0887","authenticated-orcid":false,"given":"\u00c1ureo Almeida","family":"DELGADO","sequence":"additional","affiliation":[{"name":"Universidade Federal de Juiz de Fora,  Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2026]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","article-title":"Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis","volume":"8","author":"Li Y","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","first-page":"53","article-title":"Consenso Nacional sobre H. pylori e afec\u00e7\u00f5es associadas","volume":"15","author":"Coelho LGV","year":"1996","journal-title":"GED Gastroenterol Endosc Dig"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1590\/S0004-28032005000200012","article-title":"II Consenso Brasileiro sobre H. pylori","volume":"42","author":"Coelho LG","year":"2005","journal-title":"Arq Gastroenterol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S0004-28032013005000001","article-title":"3rd Brazilian Consensus on H. pylori","volume":"50","author":"Coelho LG","year":"2013","journal-title":"Arq Gastroenterol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1590\/s0004-2803.201800000-20","article-title":"IVth Brazilian Consensus Conference on Helicobacter Pylori Infection","volume":"55","author":"Coelho LGV","year":"2018","journal-title":"Arq Gastroenterol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"102203","DOI":"10.1016\/j.mib.2022.102203","article-title":"Targeting Helicobacter pylori for antibacterial drug discovery with novel therapeutics","volume":"70","author":"Vita NA","year":"2022","journal-title":"Curr Opin Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"7587","DOI":"10.3748\/wjg.v22.i33.7587","article-title":"Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey","volume":"22","author":"Sanches BS","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref8","article-title":"Clarithromycin-resistant H. pylori primary strains and virulence genotypes in the Northeastern region of Brazil","volume":"64","author":"Benigno TGDS","year":"2022","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"ref9","article-title":"Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp-BrazilReg)","volume":"30","author":"Sanches BSF","year":"2025","journal-title":"Helicobacter"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S","DOI":"10.1016\/S0016-5085(26)06295-5","article-title":"First-line empirical eradication therapy for Helicobacter pylori infection: experience from 1,500 cases of the Brazilian Registry on H. pylori Management (Hp-BrazilReg\/WorldHpReg)","volume":"170","author":"Chaves SR","year":"2026","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/gutjnl-2015-309252","article-title":"Kyoto global consensus report on Helicobacter pylori gastritis","volume":"64","author":"Sugano K","year":"2015","journal-title":"Gut"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/ebnurs-2020-103303","article-title":"What are Delphi studies?","volume":"23","author":"Barrett D","year":"2020","journal-title":"Evid Based Nurs"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt GH","year":"2008","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt GH","year":"2008","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cgh.2013.02.001","article-title":"The AGA Institute process for developing clinical practice guidelines part one: grading the evidence","volume":"11","author":"Sultan S","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global Prevalence of Helicobacter pylori Infection and Incidence of Gastric Cancer Between 1980 and 2022","volume":"166","author":"Chen YC","year":"2024","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/MCG.0000000000001719","article-title":"Helicobacter pylori World Gastroenterology Organization Global Guideline","volume":"57","author":"Katelaris P","year":"2023","journal-title":"J Clin Gastroenterol"},{"key":"ref18","article-title":"Prevalence of Helicobacter pylori infection among gastroenterologists and gastroendoscopists in Brazil","volume":"62","author":"Coelho LGV","year":"2025","journal-title":"Arq Gastroenterol"},{"key":"ref19","first-page":"2631","article-title":"Prevalence of cagA, cagM, vacA and oipA genes in isolates of Helicobacter pylori obtained from hospital patients in Northeast Brazil","volume":"55","author":"Bezerra TMO","year":"2024","journal-title":"Braz J Microbiol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1590\/1516-3180.2021.0721.r2.03032022","article-title":"Prevalence of Helicobacter pylori infection among asymptomatic children in southeastern Brazil: a cross-sectional study","volume":"140","author":"Carlos ABM","year":"2022","journal-title":"Sao Paulo Med J"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/ajg.2008.61","article-title":"Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings","volume":"104","author":"Weyermann M","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5604","DOI":"10.1128\/JCM.41.12.5604-5608.2003","article-title":"Concordance of Helicobacter pylori strains within families","volume":"41","author":"Kivi M","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/gut.39.5.634","article-title":"Helicobacter pylori infection in spouses of patients with duodenal ulcers and comparison of ribosomal RNA gene patterns","volume":"39","author":"Georgopoulos SD","year":"1996","journal-title":"Gut"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00042737-200205000-00009","article-title":"Helicobacter pylori infection is unlikely to be transmitted between partners: evidence from genotypic study in partners of infected patients","volume":"14","author":"Luman W","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/gutjnl-2021-325630","article-title":"Chinese Consensus Report on Family-Based Helicobacter pylori Infection Control and Management (2021 Edition)","volume":"71","author":"Ding SZ","year":"2022","journal-title":"Gut"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/gutjnl-2022-328965","article-title":"Large-scale, national, family-based epidemiological study on Helicobacter pylori infection in China: the time to change practice for related disease prevention","volume":"72","author":"Zhou XZ","year":"2023","journal-title":"Gut"},{"key":"ref27","first-page":"72","article-title":"Helicobacter pylori, transmission routes and recurrence of infection: state of the art","volume":"89","author":"Kayali S","year":"2018","journal-title":"Acta Biomed"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5553","DOI":"10.1038\/s41598-025-87836-5","article-title":"The epidemiological study of family-based Helicobacter pylori screening and its benefits: a cross-sectional study","volume":"15","author":"Huang AF","year":"2025","journal-title":"Sci Rep"},{"key":"ref29","article-title":"Review: Epidemiology of Helicobacter pylori infection","volume":"4","author":"Alfaray RI","year":"2022","journal-title":"Microb Health Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41572-023-00431-8","article-title":"Helicobacter pylori infection","volume":"9","author":"Malfertheiner P","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"ref31","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12945","article-title":"Transmission routes and patterns of Helicobacter pylori","volume":"28","author":"Duan M","year":"2023","journal-title":"Helicobacter"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1330029","DOI":"10.3389\/fmicb.2023.1330029","article-title":"Helicobacter pylori infection in humans and phytotherapy, probiotics, and emerging therapeutic interventions: a review","volume":"14","author":"Liu M","year":"2024","journal-title":"Front Microbiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/diseases12120311","article-title":"Helicobacter pylori: Routes of Infection, Antimicrobial Resistance, and Alternative Therapies as a Means to Develop Infection Control","volume":"12","author":"Elbehiry A","year":"2024","journal-title":"Diseases"},{"key":"ref34","first-page":"12176","article-title":"Review of foodborne helicobacteriosis","volume":"13","author":"Almashhadany DA","year":"2024","journal-title":"Ital J Food Saf"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1093\/pubmed\/fdaf060","article-title":"Is Helicobacter pylori infection associated with animal contact? A systematic review and meta-analysis","volume":"47","author":"Wang X","year":"2025","journal-title":"J Public Health"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3390\/microorganisms11040887","article-title":"Helicobacter pylori and Human Immunodeficiency Virus co-infection: potential implications for future gastric cancer risk","volume":"11","author":"Nkuize M","year":"2023","journal-title":"Microorganisms"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"100385","DOI":"10.1016\/j.metop.2025.100385","article-title":"Helicobacter pylori infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetes","volume":"27","author":"Maleki N","year":"2025","journal-title":"Metabol Open"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.14309\/ajg.0000000000002968","article-title":"ACG Clinical Guideline: Treatment of Helicobacter pylori infection","volume":"119","author":"Chey WD","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00420-018-1315-6","article-title":"The occupational risk of Helicobacter pylori infection: a systematic review","volume":"91","author":"Kheyre H","year":"2018","journal-title":"Int Arch Occup Environ Health"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1128\/JCM.36.9.2772-2774.1998","article-title":"Detection of Helicobacter pylori in stool specimens by PCR and antigen enzyme immunoassay","volume":"36","author":"Makristathis A","year":"1998","journal-title":"J Clin Microbiol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0140-6736(93)90191-I","article-title":"Helicobacter pylori in dental plaque","volume":"341","author":"Banatvala N","year":"1993","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1177\/154411130301400307","article-title":"Oral Helicobacter pylori: can we stomach it?","volume":"14","author":"Dowsett SA","year":"2003","journal-title":"Crit Rev Oral Biol Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/gut.48.3.287","article-title":"Blood, urine, stool, breath, money, and Helicobacter pylori","volume":"48","author":"Vaira D","year":"2001","journal-title":"Gut"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s00535-024-02114-x","article-title":"Global H. pylori recurrence, recrudescence, and re-infection status after successful eradication in pediatric patients: a systematic review and meta-analysis","volume":"59","author":"Xu L","year":"2024","journal-title":"J Gastroenterol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3390\/antibiotics9060293","article-title":"The Puzzle of Coccoid Forms of Helicobacter pylori: Beyond Basic Science","volume":"9","author":"Ierardi E","year":"2020","journal-title":"Antibiotics"},{"key":"ref46","article-title":"The recurrence rate of Helicobacter pylori in recent 10 years: A systematic review and meta-analysis","volume":"26","author":"Zhao H","year":"2021","journal-title":"Helicobacter"},{"key":"ref47","first-page":"110","article-title":"H. pylori reinfection rates and serological evaluation in a 6.4 year follow-up study from a developing country","volume":"45","author":"Coelho LG","year":"1999","journal-title":"Gut"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1523-5378.2006.00434.x","article-title":"Helicobacter pylori recurrence in patients with duodenal ulcer: Clinical, endoscopic, histologic, and genotypic aspects. A 10-year Brazilian series","volume":"11","author":"Eisig JN","year":"2006","journal-title":"Helicobacter"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1523-5378.2009.00734.x","article-title":"Helicobacter pylori reinfection in Brazilian patients with peptic ulcer disease: a 5-year follow-up","volume":"15","author":"Silva FM","year":"2010","journal-title":"Helicobacter"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1136\/gutjnl-2023-331164","article-title":"RE.GA.IN.: the Real-world Gastritis Initiative-updating the updates","volume":"73","author":"Rugge M","year":"2024","journal-title":"Gut"},{"key":"ref51","first-page":"327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report","author":"Malfertheiner P","year":"2022","journal-title":"Gut"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2012.1701","article-title":"H. pylori infection and gastric cancer: state of the art (review)","volume":"42","author":"Conteduca V","year":"2013","journal-title":"Int J Oncol"},{"key":"ref53","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.71016","article-title":"Validation of the ABC Method for Gastric Cancer Risk Stratification Across Helicobacter pylori Infections With Diverse CagA Status and Subtypes in Brazil","volume":"14","author":"Maruta LM","year":"2025","journal-title":"Cancer Med"},{"key":"ref54","first-page":"1161","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon MF","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/a-0859-1883","article-title":"Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de EndoscopiaDigestiva (SPED) guideline update 2019","volume":"51","author":"Pimentel-Nunes P","year":"2019","journal-title":"Endoscopy"},{"key":"ref56","series-title":"Population-based Helicobacter pylori screen-and-treat strategies for gastric cancer prevention: guidance on implementation","author":"Park JY","year":"2025"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-2036.2005.02554.x","article-title":"Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong","volume":"22","author":"Xia B","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.14309\/ajg.0000000000001843","article-title":"The Global Incidence of Peptic Ulcer Disease Is Decreasing Since the Turn of the 21st Century: A Study of the Organisation for Economic Co-Operation and Development (OECD)","volume":"117","author":"Azhari H","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12876-022-02130-2","article-title":"The global, regional and national burden of peptic ulcer disease from 1990 to 2019: a population-based study","volume":"22","author":"Xie X","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1136\/gut.52.2.186","article-title":"Risk factors for peptic ulcer disease: a population based prospective cohort study comprising 2416 Danish adults","volume":"52","author":"Rosenstock S","year":"2003","journal-title":"Gut"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cgh.2011.12.036","article-title":"Helicobacter pylori infection is strongly associated with gastric and duodenal ulcers in a large prospective study","volume":"10","author":"Sch\u00f6ttker B","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.3748\/wjg.v29.i44.5882","article-title":"Changing trends and characteristics of peptic ulcer disease: A multicenter study from 2010 to 2019 in Korea","volume":"29","author":"Choi YJ","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0016-5085(95)90374-7","article-title":"Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease","volume":"109","author":"El-Omar EM","year":"1995","journal-title":"Gastroenterology"},{"key":"ref64","series-title":"Tratado Ilustrado de Endoscopia Digestiva","first-page":"295","volume-title":"\u00dalcera p\u00e9ptica","author":"Coelho LGV","year":"2018"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1001\/jama.2024.19094","article-title":"Peptic Ulcer Disease: A Review","volume":"332","author":"Vakil N","year":"2024","journal-title":"JAMA"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1083-4389.2004.00194.x","article-title":"Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients","volume":"9","author":"Miwa H","year":"2004","journal-title":"Helicobacter"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1053\/gast.1997.v113.pm9322501","article-title":"Prevention of ulcer recurrence after eradication of Helicobacter pylori: a prospective long-term follow-up study","volume":"113","author":"Van der Hulst RW","year":"1997","journal-title":"Gastroenterology"},{"key":"ref68","first-page":"CD003840","article-title":"Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people","volume":"4","author":"Ford AC","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for uninvestigated dyspepsia: a meta-analysis","volume":"64","author":"Ford AC","year":"2015","journal-title":"Gut"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1053\/j.gastro.2016.02.011","article-title":"Gastroduodenal Disorders","volume":"150","author":"Stanghellini V","year":"2016","journal-title":"Gastroenterology"},{"key":"ref71","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2013.3","article-title":"Helicobacter Pylori \u201cTest-and-Treat\u201d Strategy for Management of Dyspepsia: A Comprehensive Review","volume":"4","author":"Gisbert JP","year":"2013","journal-title":"Clin Transl Gastroenterol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39479.640486.AE","article-title":"Helicobacter pylori test and treat versus proton pump inhibitor in initial management of dyspepsia in primary care: multicentre randomised controlled trial (MRC-CUBE trial)","volume":"336","author":"Delaney BC","year":"2008","journal-title":"BMJ"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"101637","DOI":"10.1016\/j.bpg.2019.101637","article-title":"Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit","volume":"40-41","author":"Koletzko L","year":"2019","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref74","first-page":"CD001961","article-title":"WITHDRAWN: Initial management strategies for dyspepsia","author":"Delaney B","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ajg.2016.563","article-title":"ACG clinical guideline: treatment of Helicobacter pylori Infection","volume":"112","author":"Chey WD","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"ref76","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12693","article-title":"Helicobacter pylori \u201cTest-and-Treat\u201d strategy with urea breath test: a cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative","volume":"25","author":"Beresniak A","year":"2020","journal-title":"Helicobacter"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"l6483","DOI":"10.1136\/bmj.l6483","article-title":"Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis","volume":"367","author":"Eusebi LH","year":"2019","journal-title":"BMJ"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/gutjnl-2014-307843","article-title":"Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis","volume":"64","author":"Ford AC","year":"2015","journal-title":"Gut"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1136\/gutjnl-2021-326583","article-title":"Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis","volume":"71","author":"Ford A","year":"2022","journal-title":"Gut"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.3748\/wjg.v22.i12.3486","article-title":"Helicobacter pylori eradication therapy for functional dyspepsia: Systematic review and meta-analysis","volume":"22","author":"Du L","year":"2016","journal-title":"World J Gastroenterol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"504","DOI":"10.3390\/jcm8091324","article-title":"Helicobacter pylori Eradication Therapy for Functional Dyspepsia: A Meta-Analysis by Region and H. pylori Prevalence","volume":"8","author":"Kang S","year":"2019","journal-title":"J Clin Med"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MCG.0b013e31829f2e25","article-title":"Efficacy of Helicobacter pylori Eradication Therapy on Functional Dyspepsia: A Meta-Analysis of Randomized Controlled Studies With 12-Month Follow-up","volume":"48","author":"Zhao B","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1001\/archinternmed.2011.533","article-title":"Helicobacter pylori eradication in functional dyspepsia: HEROES trial","volume":"171","author":"Mazzoleni L","year":"2011","journal-title":"Arch Intern Med"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/ajg.2017.154","article-title":"ACG and CAG clinical guideline: management of dyspepsia","volume":"112","author":"Moayyedi P","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1002\/ijc.31571","article-title":"Risk of gastric cancer among patients with gastric intestinal metaplasia","volume":"143","author":"Shao L","year":"2018","journal-title":"Int J Cancer"},{"key":"ref86","article-title":"Gastric Cancer Risk of Intestinal Metaplasia Subtypes: A Systematic Review and Meta-Analysis of Cohort Studies","volume":"12","author":"Du S","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/a-2529-5025","article-title":"Management of epithelial precancerous conditions and early neoplasia of the stomach (MAPS III): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG) and European Society of Pathology (ESP) Guideline update 2025","volume":"57","author":"Dinis-Ribeiro M","year":"2025","journal-title":"Endoscopy"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.3904\/kjim.2018.285","article-title":"Risk stratification of patients with gastric lesions indefinite for dysplasia","volume":"36","author":"Cho YS","year":"2021","journal-title":"Korean J Intern Med"},{"key":"ref89","first-page":"9460681","article-title":"Novel pathologic factors for risk stratification of gastric \u201cindefinite for dysplasia\u201d lesions","volume":"2020","author":"Yim K","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/gutjnl-2024-333029","article-title":"The road to a world-unified approach to the management of patients with gastric intestinal metaplasia: a review of current guidelines","volume":"73","author":"Dinis-Ribeiro M","year":"2024","journal-title":"Gut"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.cgh.2017.05.023","article-title":"Gastric Cancer as Preventable Disease","volume":"15","author":"Rugge M","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","article-title":"Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-up","volume":"163","author":"Yan L","year":"2022","journal-title":"Gastroenterology"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1136\/gutjnl-2020-320839","article-title":"Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis","volume":"69","author":"Ford AC","year":"2020","journal-title":"Gut"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"1530549","DOI":"10.3389\/fmicb.2025.1530549","article-title":"Effect of Helicobacter pylori eradication on gastric cancer risk in patients with intestinal metaplasia or dysplasia: a meta-analysis of randomized controlled trials","volume":"16","author":"Fu Q","year":"2025","journal-title":"Front Microbiol"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2020.11.017","article-title":"The Colombian Chemoprevention Trial: 20-Year Follow-Up of a Cohort of Patients With Gastric Precancerous Lesions","volume":"160","author":"Piazuelo MB","year":"2021","journal-title":"Gastroenterology"},{"key":"ref96","series-title":"Digestive System Tumours","volume-title":"WHO Classification of Tumours Editorial Board","year":"2019","edition":"5th ed"},{"key":"ref97","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12308-017-0302-2","article-title":"Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma","volume":"10","author":"Schreuder MI","year":"2017","journal-title":"J Hematop"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0140-6736(91)92035-Z","article-title":"Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma","volume":"338","author":"Wotherspoon AC","year":"1991","journal-title":"Lancet"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/annonc\/mdp402","article-title":"Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pylori interventions","volume":"21","author":"Luminari S","year":"2010","journal-title":"Ann Oncol"},{"key":"ref100","first-page":"485","article-title":"Endoscopic and clinicopathological features of primary gastric lymphoma","volume":"40","author":"Takeshita K","year":"1993","journal-title":"Hepatogastroenterology"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/j.1440-1746.2011.06729.x","article-title":"Target biopsy using magnifying endoscopy in clinical management of gastric mucosa-associated lymphoid tissue lymphoma","volume":"26","author":"Ono S","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"ref102","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca E","year":"2020","journal-title":"Ann Oncol"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-F","article-title":"Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori","volume":"342","author":"Wotherspoon AC","year":"1993","journal-title":"Lancet"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1136\/gut.52.11.1656","article-title":"Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma","volume":"52","author":"Copie-Bergman C","year":"2003","journal-title":"Gut"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/MCG.0b013e318286ff72","article-title":"Eradication therapy in Helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: a systematic review","volume":"47","author":"Zullo A","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"ref106","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/CM9.0000000000000813","article-title":"Clinical efficacy of the modified Helicobacter pylori eradication therapy for Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma: a meta analysis","volume":"133","author":"Xie YL","year":"2020","journal-title":"Chin Med J"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1590\/S0004-28032014000200003","article-title":"Helicobacter pylori and t(11;18)(q21;q21) translocation in gastric MALT lymphoma","volume":"51","author":"Lima KS","year":"2014","journal-title":"Arq Gastroenterol"},{"key":"ref108","doi-asserted-by":"crossref","first-page":"524","DOI":"10.15403\/jgld-5959","article-title":"The Landscape of Helicobacter pylori-related Gastric Carcinogenesis","volume":"33","author":"Assump\u00e7\u00e3o PP","year":"2024","journal-title":"J Gastrointestin Liver Dis"},{"key":"ref109","first-page":"1523","article-title":"Helicobacter pylori and Gastric Cancer: Pathogenetic Mechanisms","volume":"47","author":"Salvatori S","year":"2024","journal-title":"Cell Oncol"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1126\/science.aaf9011","article-title":"Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention","volume":"355","author":"Tomasetti C","year":"2017","journal-title":"Science"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q","article-title":"Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin","volume":"6","author":"Slaughter DP","year":"1953","journal-title":"Cancer"},{"key":"ref112","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.3748\/wjg.v20.i11.2765","article-title":"Helicobacter pylori infection following partial gastrectomy for gastric cancer","volume":"20","author":"Park S","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa1708423","article-title":"Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer","volume":"378","author":"Choi J","year":"2018","journal-title":"N Engl J Med"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(08)61159-9","article-title":"Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection","volume":"372","author":"Fukase K","year":"2008","journal-title":"Lancet"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2024.12.033","article-title":"Eradication Therapy to Prevent Gastric Cancer in Helicobacter pylori-Positive Individuals: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies","volume":"169","author":"Ford AC","year":"2025","journal-title":"Gastroenterology"},{"key":"ref116","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3812","article-title":"Anti-Helicobacter pylori Treatment in Patients With Gastric Cancer After Radical Gastrectomy","volume":"7","author":"Zhao Z","year":"2024","journal-title":"JAMA Netw Open"},{"key":"ref117","first-page":"2531","article-title":"A five-year follow-up study on the eradication of Helicobacter pylori in patients after gastric cancer surgery","volume":"132","author":"Zhou L","year":"2019","journal-title":"Chin Med J"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa1909666","article-title":"Family History of Gastric Cancer and Helicobacter pylori Treatment","volume":"382","author":"Choi IJ","year":"2020","journal-title":"N Engl J Med"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/apt.17872","article-title":"Systematic review and meta-analysis: Risk of gastric cancer in patients with first-degree relatives with gastric cancer","volume":"59","author":"Ligato I","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00428-013-1458-5","article-title":"First-degree relatives of early-onset gastric cancer patients show a high risk for gastric cancer: phenotype and genotype profile","volume":"463","author":"Marcos-Pinto R","year":"2013","journal-title":"Virchows Arch"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1365-2036.2012.05111.x","article-title":"First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA\/OLGIM stages and dysplasia","volume":"35","author":"Marcos-Pinto R","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref122","first-page":"532","article-title":"Consensus recommendations for the screening, diagnosis, and management of Helicobacter pylori infection in Hong Kong","volume":"29","author":"Leung WK","year":"2023","journal-title":"Hong Kong Med J"},{"key":"ref123","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2147\/PPA.S286860","article-title":"Cost-effectiveness Analysis of Helicobacter pylori Eradication Therapy in First-Degree Relatives of Patients with Gastric Cancer","volume":"15","author":"Zheng H","year":"2021","journal-title":"Patient Prefer Adherence"},{"key":"ref124","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000546653","article-title":"Interaction Effect of Helicobacter pylori Infection and Family History of Gastric Cancer on the Detection Age of Significant Gastric Precancerous Conditions","volume":"43","author":"Quach DT","year":"2025","journal-title":"Dig Dis"},{"key":"ref125","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1136\/gutjnl-2024-333684","article-title":"Commentary on: the management of patients with gastric intestinal metaplasia","volume":"74","author":"Graham DY","year":"2025","journal-title":"Gut"},{"key":"ref126","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0140-6736(02)07273-2","article-title":"Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis","volume":"359","author":"Huang JQ","year":"2002","journal-title":"Lancet"},{"key":"ref127","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41569-024-01028-8","article-title":"Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease","volume":"21","author":"W\u00e4rme J","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"ref128","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(22)01843-8","article-title":"Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial","volume":"400","author":"Hawkey C","year":"2022","journal-title":"Lancet"},{"key":"ref129","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/apt.14652","article-title":"Contribution of Helicobacter pylori infection to the risk of peptic ulcer bleeding in patients on nonsteroidal anti-inflammatory drugs, antiplatelet agents, anticoagulants, corticosteroids and selective serotonin reuptake inhibitors","volume":"47","author":"Venerito M","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3892\/etm.2020.9335","article-title":"Reducing upper digestive bleeding risk in patients treated with direct oral anticoagulants and concomitant infection with Helicobacter pylori","volume":"20","author":"Suceveanu AI","year":"2020","journal-title":"Exp Ther Med"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/s41591-025-03624-8","article-title":"Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study","volume":"31","author":"Lee S","year":"2025","journal-title":"Nat Med"},{"key":"ref132","doi-asserted-by":"crossref","first-page":"1552630","DOI":"10.3389\/fmicb.2025.1552630","article-title":"Research progress on the relationship between Helicobacter pylori infection and iron deficiency anemia","volume":"16","author":"Pu S","year":"2025","journal-title":"Front Microbiol"},{"key":"ref133","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1053\/j.gastro.2020.06.046","article-title":"AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia","volume":"159","author":"Ko CW","year":"2020","journal-title":"Gastroenterology"},{"key":"ref134","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1523-5378.2008.00617.x","article-title":"Helicobacter pylori infection and iron stores: a systematic review and meta-analysis","volume":"13","author":"Muhsen K","year":"2008","journal-title":"Helicobacter"},{"key":"ref135","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12330","article-title":"An updated systematic review and meta-analysis on the association between Helicobacter pylori infection and iron deficiency anemia","volume":"22","author":"Hudak L","year":"2017","journal-title":"Helicobacter"},{"key":"ref136","first-page":"886","article-title":"Does Helicobacter pylori infection play a role in iron deficiency anemia? A meta-analysis","volume":"16","author":"Qu XH","year":"2010","journal-title":"World J Gastroenterol"},{"key":"ref137","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1136\/pgmj.2009.089987","article-title":"Iron deficiency anaemia can be improved after eradication of Helicobacter pylori","volume":"86","author":"Huang X","year":"2010","journal-title":"Postgrad Med J"},{"key":"ref138","first-page":"1924","article-title":"Effect of Helicobacter pylori eradication on iron deficiency","volume":"123","author":"Zhang ZF","year":"2010","journal-title":"Chin Med J"},{"key":"ref139","doi-asserted-by":"crossref","first-page":"850","DOI":"10.3324\/haematol.2008.005348","article-title":"Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura: a systematic review","volume":"94","author":"Arnold DM","year":"2009","journal-title":"Haematologica"},{"key":"ref140","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(05)60004-9","article-title":"Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori","volume":"352","author":"Gasbarrini A","year":"1998","journal-title":"Lancet"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"9370","DOI":"10.1038\/s41598-020-66460-5","article-title":"Helicobacter pylori eradication affects platelet count recovery in immune thrombocytopenia","volume":"10","author":"Lee A","year":"2020","journal-title":"Sci Rep"},{"key":"ref142","first-page":"6090878","article-title":"Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials","volume":"2018","author":"Kim BJ","year":"2018","journal-title":"Gastroenterol Res Pract"},{"key":"ref143","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bjhh.2017.09.005","article-title":"Platelet count response to Helicobacter pylori eradication for idiopathic thrombocytopenic purpura in northeastern Brazil","volume":"40","author":"Barbosa AMC","year":"2018","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref144","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3109\/09537104.2014.911836","article-title":"Helicobacter pylori infection & immune thrombocytopenic purpura in children and adolescents: A randomized controlled trial","volume":"26","author":"Brito HS","year":"2015","journal-title":"Platelets"},{"key":"ref145","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","journal-title":"Blood Adv"},{"key":"ref146","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0140-6736(84)91523-X","article-title":"Campylobacter-like organisms unusual in type a (pernicious anaemia) gastritis","volume":"2","author":"O\u2019Connor HJ","year":"1984","journal-title":"Lancet"},{"key":"ref147","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1056\/NEJMcp1113996","article-title":"Vitamin B12 deficiency","volume":"368","author":"Stabler SP","year":"2013","journal-title":"N Engl J Med"},{"key":"ref148","first-page":"346","article-title":"Helicobacter pylori, a causative agent of vitamin B12 deficiency","volume":"2","author":"Sarari AS","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"ref149","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00004836-200302000-00008","article-title":"An association between Helicobacter pylori infection and serum vitamin B12 levels in healthy adults","volume":"36","author":"Shuval-Sudai O","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"ref150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000535206","article-title":"Iron and Vitamin B12 Deficiency in Patients with Autoimmune Gastritis and Helicobacter pylori Gastritis","volume":"42","author":"Osmola M","year":"2024","journal-title":"Dig Dis"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.htct.2017.11.010","article-title":"Hematological parameters, serum iron and vitamin B12 levels in hospitalized Palestinian adult patients infected with Helicobacter pylori: a case-control study","volume":"40","author":"Mwafy SN","year":"2018","journal-title":"Hematol Transfus Cell Ther"},{"key":"ref152","first-page":"225","article-title":"Diagnostic and therapeutic recommendations on Helicobacter pylori infection","volume":"18","author":"Jaro\u0144 K","year":"2023","journal-title":"Prz Gastroenterol"},{"key":"ref153","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1053\/gast.2001.29332","article-title":"Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease","volume":"121","author":"Moayyedi P","year":"2001","journal-title":"Gastroenterology"},{"key":"ref154","first-page":"423","article-title":"Relationship between Helicobacter pylori infection and gastroesophageal reflux disease","volume":"16","author":"Y\u0131lmaz S","year":"2024","journal-title":"Prz Gastroenterol"},{"key":"ref155","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1111\/jgh.70009","article-title":"Helicobacter pylori Infection and Eradication in Relation to Gastroesophageal Reflux Disease","volume":"40","author":"Wang H","year":"2025","journal-title":"J Gastroenterol Hepatol"},{"key":"ref156","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/apt.13324","article-title":"Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology","volume":"42","author":"Lundell L","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref157","doi-asserted-by":"crossref","first-page":"11962","DOI":"10.3748\/wjg.v20.i34.11962","article-title":"Potential mechanism of corpus-predominant gastritis after PPI therapy in Helicobacter pylori-positive patients with GERD","volume":"20","author":"Mukaisho K","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref158","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.dld.2022.06.019","article-title":"Management of Helicobacter pylori infection: Guidelines of the Italian Society of Gastroenterology (SIGE) and the Italian Society of Digestive Endoscopy (SIED)","volume":"54","author":"Romano M","year":"2022","journal-title":"Dig Liver Dis"},{"key":"ref159","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1046\/j.1523-5378.2000.00032.x","article-title":"Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression","volume":"5","author":"Moayyedi P","year":"2008","journal-title":"Helicobacter"},{"key":"ref160","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11894-017-0577-6","article-title":"The gastric and intestinal microbiome: role of proton pump inhibitors","volume":"19","author":"Minalyan A","year":"2017","journal-title":"Curr Gastroenterol Rep"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1053\/j.gastro.2024.06.038","article-title":"AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review","volume":"167","author":"Patel A","year":"2024","journal-title":"Gastroenterology"},{"key":"ref162","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrgastro.2017.117","article-title":"Proton-Pump inhibitors: understanding the complications and risks","volume":"14","author":"Malfertheiner P","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref163","doi-asserted-by":"crossref","first-page":"222","DOI":"10.4103\/sjg.SJG_573_16","article-title":"Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis","volume":"23","author":"Li Z","year":"2017","journal-title":"Saudi J Gastroenterol"},{"key":"ref164","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s15010-024-02244-7","article-title":"Estimates of global and regional prevalence of Helicobacter pylori infection among individuals with obesity: a systematic review and meta-analysis","volume":"52","author":"Sadeghi A","year":"2024","journal-title":"Infection"},{"key":"ref165","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1007\/s11695-020-04720-z","article-title":"IFSO Position Statement on the Role of Esophago-Gastro-Duodenal Endoscopy Prior to and after Bariatric and Metabolic Surgery Procedures","volume":"30","author":"Brown WA","year":"2020","journal-title":"Obes Surg"},{"key":"ref166","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.soard.2021.03.007","article-title":"ASMBS position Statement on the rationale for performance of upper gastrointestinal endoscopy before and after metabolic and bariatric surgery","volume":"17","author":"Campos GM","year":"2021","journal-title":"Surg Obes Relat Dis"},{"key":"ref167","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s11695-023-06481-x","article-title":"Perioperative Interventions to Prevent Gastroesophageal Reflux Disease and Marginal Ulcers After Bariatric Surgery - an International Experts\u2019 Survey","volume":"33","author":"Chiappetta S","year":"2023","journal-title":"Obes Surg"},{"key":"ref168","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00464-022-09656-2","article-title":"Indications for upper gastrointestinal endoscopy before bariatric surgery: a multicenter study","volume":"37","author":"Abdallah H","year":"2023","journal-title":"Surg Endosc"},{"key":"ref169","article-title":"Impact of Helicobacter pylori on early postoperative complications after sleeve gastrectomy: a systematic review and meta-analysis","volume":"36","author":"Dantas ACB","year":"2024","journal-title":"Arq Bras Cir Dig"},{"key":"ref170","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1007\/s11695-023-06858-y","article-title":"The Impact of Helicobacter pylori on Laparoscopic Sleeve Gastrectomy Postoperative Complications: a Systematic Review and Meta-analysis","volume":"33","author":"Marcolin P","year":"2023","journal-title":"Obes Surg"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.1007\/s00464-025-11849-4","article-title":"Does Helicobacter pylori infection impact reflux symptoms after sleeve gastrectomy? A pilot study using patient reported outcome measures (PROMs)","volume":"39","author":"Amaniera I","year":"2025","journal-title":"Surg Endosc"},{"key":"ref172","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s11605-023-05619-7","article-title":"Predictors of marginal ulcer after gastric bypass: a systematic review and meta-analysis","volume":"27","author":"Beran A","year":"2023","journal-title":"J Gastrointest Surg"},{"key":"ref173","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s13304-025-02151-y","article-title":"Effect of Helicobacter pylori infection on metabolic and bariatric surgical complications: a systematic review and meta-analysis","volume":"77","author":"Kermansaravi M","year":"2025","journal-title":"Updates Surg"},{"key":"ref174","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.soard.2024.10.013","article-title":"American Society for Metabolic and Bariatric Surgery literature review on risk factors, screening recommendations, and prophylaxis for marginal ulcers after metabolic and bariatric surgery","volume":"21","author":"Vosburg RW","year":"2025","journal-title":"Surg Obes Relat Dis"},{"key":"ref175","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.11.059","article-title":"AGA Clinical Practice Update on the Management of Refractory Helicobacter pylori Infection: Expert Review","volume":"160","author":"Shah SC","year":"2021","journal-title":"Gastroenterology"},{"key":"ref176","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1590\/S0100-879X1999001200007","article-title":"Application of isotope-selective non-dispersive infrared spectrometry for the evaluation of the 13C-urea breath test: comparison with three concordant methods","volume":"32","author":"Coelho LG","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"ref177","first-page":"39","article-title":"13C-urea breath test with infrared spectroscopy for diagnosing H. pylori infection in children and adolescents","volume":"35","author":"Kawakami E","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref178","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1523-5378.2011.00863.x","article-title":"13C-urea breath test for the diagnosis of H. pylori infection in children: a systematic review and meta-analysis","volume":"16","author":"Leal YA","year":"2011","journal-title":"Helicobacter"},{"key":"ref179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2023.1323113","article-title":"A comparative systematic review and meta-analysis on the diagnostic accuracy of non-invasive tests for Helicobacter pylori detection in elderly patients","volume":"10","author":"Omar M","year":"2023","journal-title":"Front Med"},{"key":"ref180","first-page":"CD012080","article-title":"Non-invasive diagnostic tests for Helicobacter pylori infection","author":"Best L","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3748\/wjg.v30.i6.579","article-title":"Urea breath test for Helicobacter pylori infection in adult dyspeptic patients: a meta-analysis of diagnostic test accuracy","volume":"30","author":"Lemos F","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref182","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1572-0241.1999.01069.x","article-title":"Citric acid as the test meal for the 13C-urea breath test","volume":"94","author":"Graham DY","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref183","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2018\/e16-553","article-title":"Performance of the 13C-urea breath test for the diagnosis of H. pylori infection using a substrate synthesized in Brazil: a preliminary study","volume":"73","author":"Coelho LG","year":"2018","journal-title":"Clinics"},{"key":"ref184","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clinre.2014.02.001","article-title":"Accuracy of stool antigen test for the diagnosis of H. pylori infection in children: a meta-analysis","volume":"38","author":"Zhou X","year":"2014","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref185","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/j.1572-0241.2006.00668.x","article-title":"Accuracy of monoclonal stool antigen test for the diagnosis of H. pylori infection: a systematic review and meta-analysis","volume":"101","author":"Gisbert JP","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref186","first-page":"P10.14","article-title":"Evaluation of stool antigen test on initial diagnosis and control test of Helicobacter pylori eradication","volume":"18","author":"Sanches BSF","year":"2013","journal-title":"Helicobacter"},{"key":"ref187","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPG.0b013e3181ac6770","article-title":"Validation of a monoclonal stool antigen test for diagnosing Helicobacter pylori infection in young children","volume":"50","author":"Raguza D","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref188","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0889-8553(05)70152-7","article-title":"Accurate diagnosis of Helicobacter pylori: serologic testing","volume":"29","author":"Ho B","year":"2000","journal-title":"Gastroenterol Clin North Am"},{"key":"ref189","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013248","article-title":"Accuracy of testing for anti-Helicobacter pylori IgG in urine for H. pylori infection diagnosis: a systematic review and meta-analysis","volume":"7","author":"Gong Y","year":"2017","journal-title":"BMJ Open"},{"key":"ref190","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01084-24","article-title":"Diagnosis of Helicobacter pylori infection: serology vs. urea breath test","volume":"12","author":"Imperial M","year":"2024","journal-title":"Microbiol Spectr"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/003655200750024290","article-title":"Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology","volume":"35","author":"Kokkola A","year":"2000","journal-title":"Scand J Gastroenterol"},{"key":"ref192","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1136\/gutjnl-2017-314109","article-title":"Quality standards in upper gastrointestinal endoscopy: a position Statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS)","volume":"66","author":"Beg S","year":"2017","journal-title":"Gut"},{"key":"ref193","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10120-024-01494-6","article-title":"Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019","volume":"27","author":"Li Y","year":"2024","journal-title":"Gastric Cancer"},{"key":"ref194","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.31557\/APJCP.2019.20.8.2253","article-title":"Disparities in Epidemiological Profile of Adenocarcinoma in Selected Cities of Brazil","volume":"20","author":"Curado MP","year":"2019","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref195","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1136\/gutjnl-2020-322368","article-title":"Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei Global consensus","volume":"69","author":"Liou JM","year":"2020","journal-title":"Gut"},{"key":"ref196","first-page":"10","article-title":"Diagnosis of Helicobacter pylori by invasive test: histology","volume":"3","author":"Lee JY","year":"2015","journal-title":"Ann Transl Med"},{"key":"ref197","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1053\/j.gastro.2021.06.078","article-title":"AGA Clinical Practice Update on the Diagnosis and Management of Atrophic Gastritis: Expert Review","volume":"161","author":"Shah SC","year":"2021","journal-title":"Gastroenterology"},{"key":"ref198","article-title":"A Comparison Between Histology and Rapid Urease Test in the Diagnosis of Helicobacter Pylori in Gastric Biopsies: A Systematic Review","volume":"15","author":"Urgessa NA","year":"2023","journal-title":"Cureus"},{"key":"ref199","first-page":"9","article-title":"Diagnosis of Helicobacter pylori using the rapid urease test","volume":"3","author":"Uotani T","year":"2015","journal-title":"Ann Transl Med"},{"key":"ref200","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0016-5107(00)70412-3","article-title":"A prospective evaluation of new rapid urease tests before and after eradication treatment of Helicobacter pylori, in comparison with histology, culture and 13C-urea breath test","volume":"51","author":"Nishikawa K","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"ref201","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciy584","article-title":"A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology","volume":"67","author":"Miller JM","year":"2018","journal-title":"Clin Infect Dis"},{"key":"ref202","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4103\/ijmm.IJMM_17_246","article-title":"Detection of clarithromycin-resistant Helicobacter pylori by polymerase chain reaction using residual samples from rapid urease test","volume":"35","author":"Jeon JS","year":"2017","journal-title":"Indian J Med Microbiol"},{"key":"ref203","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/diagnostics11081458","article-title":"Current Helicobacter pylori diagnostics","volume":"11","author":"Bordin DS","year":"2021","journal-title":"Diagnostics"},{"key":"ref204","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.3390\/jcm10102091","article-title":"What is new in Helicobacter pylori diagnosis: An Overview","volume":"10","author":"Dore MP","year":"2021","journal-title":"J Clin Med"},{"key":"ref205","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/MEG.0000000000002704","article-title":"Gastric juice analysis in clinical practice: why, how, and when. The experience with EndoFaster","volume":"36","author":"Zullo A","year":"2024","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref206","first-page":"165","article-title":"Peptic Ulcer Disease and H. pylori Infection: Common Questions and Answers","volume":"107","author":"McConaghy JR","year":"2023","journal-title":"Am Fam Physician"},{"key":"ref207","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/jpn3.12314","article-title":"Updated joint ESPGHAN\/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023)","volume":"79","author":"Homan M","year":"2024","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref208","doi-asserted-by":"crossref","first-page":"5921","DOI":"10.3390\/molecules28155921","article-title":"Biological Activities of Bismuth Compounds: An Overview","volume":"28","author":"Ros\u00e1rio JDS","year":"2023","journal-title":"Molecules"},{"key":"ref209","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1111\/j.1572-0241.1999.01361.x","article-title":"Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection","volume":"94","author":"Bravo LE","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"ref210","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1572-0241.2004.30162.x","article-title":"Effect of proton pump inhibitors and antacid therapy on 13C urea breath tests and stool test for Helicobacter pylori infection","volume":"99","author":"Gatta L","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10620-016-4439-0","article-title":"Effect of Vonoprazan, a Potassium-Competitive Acid Blocker, on the 13C-Urea Breath Test in Helicobacter pylori-Positive Patients","volume":"62","author":"Takimoto M","year":"2017","journal-title":"Dig Dis Sci"},{"key":"ref212","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2003.07426.x","article-title":"Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors","volume":"98","author":"Graham DY","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref213","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/ueg2.12099","article-title":"European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC","volume":"9","author":"Keller J","year":"2021","journal-title":"United European Gastroenterol J"},{"key":"ref214","first-page":"657","article-title":"Tunisian consensus on the management of Helicobacter Pylori infection","volume":"101","author":"Medhioub M","year":"2023","journal-title":"Tunis Med"},{"key":"ref215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1572-0241.2001.03517.x","article-title":"Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori","volume":"96","author":"Savarino V","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref216","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/A:1021931627698","article-title":"Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test","volume":"48","author":"Dulbecco P","year":"2003","journal-title":"Dig Dis Sci"},{"key":"ref217","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/gast.1996.v110.pm8608880","article-title":"Sucralfate suppresses Helicobacter pylori infection and reduces gastric acid secretion by 50% in patients with duodenal ulcer","volume":"110","author":"Banerjee S","year":"1996","journal-title":"Gastroenterology"},{"key":"ref218","first-page":"595","article-title":"Effect of sucralfate on the degradation of human gastric mucus by Helicobacter pylori protease and lipases","volume":"87","author":"Slomiany BL","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"ref219","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00535-003-1176-x","article-title":"Influence of anti-ulcer drugs used in Japan on the result of (13)C-urea breath test for the diagnosis of Helicobacter pylori infection","volume":"38","author":"Murakami K","year":"2003","journal-title":"J Gastroenterol"},{"key":"ref220","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/00365529509090279","article-title":"Effect of sucralfate on Helicobacter pylori and severity of gastritis in patients with duodenal ulcer","volume":"210","author":"Winter TA","year":"1995","journal-title":"Scand J Gastroenterol Suppl"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1038\/s41598-022-07947-1","article-title":"Relevance of pepsinogen, gastrin, and endoscopic atrophy in the diagnosis of autoimmune gastritis","volume":"12","author":"Kishikawa H","year":"2022","journal-title":"Sci Rep"},{"key":"ref222","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s12876-025-03996-8","article-title":"The potential value of serum pepsinogen and gastrin-17 for the diagnosis of chronic atrophic gastritis at different stages of severity: a clinical diagnostic study","volume":"25","author":"Zhang T","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"ref223","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026957","article-title":"Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis","volume":"6","author":"Nasrollahzadeh D","year":"2011","journal-title":"PLoS One"},{"key":"ref224","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230064","article-title":"Serum pepsinogens as a gastric cancer and gastritis biomarker in South and Southeast Asian populations","volume":"15","author":"Miftahussurur M","year":"2020","journal-title":"PLoS One"},{"key":"ref225","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/apt.14248","article-title":"Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis","volume":"46","author":"Zagari RM","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref226","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cgh.2021.01.009","article-title":"Pepsinogens and Gastrin Demonstrate Low Discrimination for Gastric Precancerous Lesions in a Multi-Ethnic United States Cohort","volume":"20","author":"Huang RJ","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref227","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/s0004-2803.202100000-08","article-title":"Helicobacter pylori chronic gastritis on patients with premalignant conditions: OLGA and OLGIM evaluation and serum biomarkers performance","volume":"58","author":"Coelho MCF","year":"2021","journal-title":"Arq Gastroenterol"},{"key":"ref228","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1590\/s0004-2803.202000000-29","article-title":"Diagnostic accuracy of Gastropanel\u00ae for atrophic gastritis in Brazilian subjects and the effect of proton pump inhibitors","volume":"57","author":"Mattar R","year":"2020","journal-title":"Arq Gastroenterol"},{"key":"ref229","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41395-018-0353-8","article-title":"OLGA gastritis staging for the prediction of gastric cancer risk: a long-term follow-up study of 7436 patients","volume":"113","author":"Rugge M","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"ref230","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/gutjnl-2021-324057","article-title":"Severity of gastric intestinal metaplasia predicts the risk of gastric cancer: a prospective multicentre cohort study (GCEP)","volume":"71","author":"Lee JWJ","year":"2022","journal-title":"Gut"},{"key":"ref231","first-page":"183","article-title":"The risk of diffuse-type gastric cancer following diagnosis with gastric precancerous lesions: a systematic review and meta-analysis","volume":"33","author":"Wang JE","year":"2022","journal-title":"Cancer Causes Control"},{"key":"ref232","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/gut.2006.106666","article-title":"Gastritis staging in clinical practice: the OLGA staging system","volume":"56","author":"Rugge M","year":"2007","journal-title":"Gut"},{"key":"ref233","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.gie.2009.12.029","article-title":"The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis","volume":"71","author":"Capelle LG","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"ref234","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-014-1544-3","article-title":"Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems","volume":"464","author":"Isajevs S","year":"2014","journal-title":"Virchows Arch"},{"key":"ref235","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.dld.2025.04.047","article-title":"Standardizing endoscopic protocols increases detection of gastric cancer during surveillance of patients with precancerous conditions: a systematic review and meta-analysis","volume":"57","author":"Marcos P","year":"2025","journal-title":"Dig Liver Dis"},{"key":"ref236","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1007\/s10620-019-06031-5","article-title":"Increased risk of progression to gastric adenocarcinoma in patients with non-dysplastic gastric intestinal metaplasia versus a control population","volume":"65","author":"Dhingra R","year":"2020","journal-title":"Dig Dis Sci"},{"key":"ref237","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12935-021-01869-0","article-title":"A meta-analysis and systematic review on subtypes of gastric intestinal metaplasia and neoplasia risk","volume":"21","author":"Wei N","year":"2021","journal-title":"Cancer Cell Int"},{"key":"ref238","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/jcp-2023-209209","article-title":"Staging of operative link on gastritis assessment and operative link on gastric intestinal metaplasia systems for risk assessment of early gastric cancer: a case-control study","volume":"78","author":"Huang Y","year":"2025","journal-title":"J Clin Pathol"},{"key":"ref239","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/1751-2980.13198","article-title":"Endoscopic grading of gastric atrophy and histological gastritis staging on risk assessment for early gastric cancer: A case-control study","volume":"24","author":"Chen M","year":"2023","journal-title":"J Dig Dis"},{"key":"ref240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","article-title":"The gastric precancerous cascade","volume":"13","author":"Correa P","year":"2012","journal-title":"J Dig Dis"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/den.12031","article-title":"Diagnosis of Helicobacter pylori infection in gastric mucosa by endoscopic features: a multicenter prospective study","volume":"25","author":"Kato T","year":"2013","journal-title":"Dig Endosc"},{"key":"ref242","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5946\/ce.2019.072","article-title":"Assessment of endoscopic gastric atrophy according to the Kimura-Takemoto classification and its potential application in daily practice","volume":"52","author":"Quach DT","year":"2019","journal-title":"Clin Endosc"},{"key":"ref243","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0028-1098086","article-title":"An endoscopic recognition of the atrophic border and its significance in chronic gastritis","volume":"1","author":"Kimura K","year":"1969","journal-title":"Endoscopy"},{"key":"ref244","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.gie.2016.07.064","article-title":"Acetic acid chromoendoscopy for determining the extent of gastric intestinal metaplasia","volume":"85","author":"Song KH","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"ref245","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1055\/a-0808-3186","article-title":"Endoscopic grading of gastric intestinal metaplasia (EGGIM): a multicenter validation study","volume":"51","author":"Esposito G","year":"2019","journal-title":"Endoscopy"},{"key":"ref246","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gutjnl-2015-310846","article-title":"Chronicles of a cancer foretold: 35 years of gastric cancer risk assessment","volume":"65","author":"Rugge M","year":"2016","journal-title":"Gut"},{"key":"ref247","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1111\/jgh.16617","article-title":"Endoscopic and histological risk stratification for gastric cancer using gastric intestinal metaplasia","volume":"39","author":"Kawamura M","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"key":"ref248","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/1751-2980.13346","article-title":"The Role of Endoscopic Grading of Gastric Intestinal Metaplasia (EGGIM) in Assessing the Extent and Degree of Gastric Intestinal Metaplasia","volume":"26","author":"Lyu D","year":"2025","journal-title":"J Dig Dis"},{"key":"ref249","doi-asserted-by":"crossref","first-page":"709","DOI":"10.14309\/ajg.0000000000003350","article-title":"ACG Clinical Guideline: Diagnosis and Management of Gastric Premalignant Conditions","volume":"120","author":"Morgan DR","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"ref250","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1572-0241.2000.02074.x","article-title":"Topographic patterns of intestinal metaplasia and gastric cancer","volume":"95","author":"Cassaro M","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"ref251","first-page":"299","article-title":"Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges","volume":"4","author":"Liu Z","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"ref252","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2022.03.039","article-title":"Effect of Helicobacter pylori Eradication on Gastric Cancer Prevention: Updated Report From a Randomized Controlled Trial With 26.5 Years of Follow-up","volume":"163","author":"Yan L","year":"2022","journal-title":"Gastroenterology"},{"key":"ref253","doi-asserted-by":"crossref","first-page":"3250","DOI":"10.1038\/s41591-024-03153-w","article-title":"Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial","volume":"30","author":"Pan KF","year":"2024","journal-title":"Nat Med"},{"key":"ref254","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gutjnl-2020-322200","article-title":"Mass eradication of Helicobacter pylori to reduce gastric cancer incidence and mortality: a long-term cohort study on Matsu Islands","volume":"70","author":"Chiang TH","year":"2021","journal-title":"Gut"},{"key":"ref255","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1136\/gutjnl-2021-325948","article-title":"Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation","volume":"71","author":"Wang Z","year":"2022","journal-title":"Gut"},{"key":"ref256","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1053\/j.gastro.2024.11.001","article-title":"AGA Clinical Practice Update on Screening and Surveillance in Individuals at Increased Risk for Gastric Cancer in the United States: Expert Review","volume":"168","author":"Shah SC","year":"2025","journal-title":"Gastroenterology"},{"key":"ref257","series-title":"Estimativa 2023-2025: Incid\u00eancia de C\u00e2ncer no Brasil","year":"2023"},{"key":"ref258","first-page":"100608","article-title":"Recommendations for gastric cancer prevention and control in the Americas","volume":"27","author":"Riquelme A","year":"2023","journal-title":"Lancet Reg Health Am"},{"key":"ref259","article-title":"Developing a potent vaccine against Helicobacter pylori: critical considerations and challenges","volume":"27","author":"Hasanzadeh Haghighi F","year":"2024","journal-title":"Expert Rev Mol Med"},{"key":"ref260","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.vaccine.2018.01.001","article-title":"Status of vaccine research and development for Helicobacter pylori","volume":"37","author":"Sutton P","year":"2019","journal-title":"Vaccine"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3390\/vaccines13050526","article-title":"Helicobacter pylori Vaccine: Mechanism of Pathogenesis, Immune Evasion and Analysis of Vaccine Types","volume":"13","author":"Gong J","year":"2025","journal-title":"Vaccines"},{"key":"ref262","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.2147\/IDR.S412361","article-title":"How Long Will It Take to Launch an Effective Helicobacter pylori Vaccine for Humans?","volume":"16","author":"Li S","year":"2023","journal-title":"Infect Drug Resist"},{"key":"ref263","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S2468-1253(18)30125-0","article-title":"Efficacy, immunogenicity, and safety of a parenteral vaccine against Helicobacter pylori in healthy volunteers challenged with a Cag-positive strain: a randomised, placebo-controlled phase 1\/2 study","volume":"3","author":"Malfertheiner P","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref264","doi-asserted-by":"crossref","first-page":"101470","DOI":"10.1016\/j.jcmgh.2025.101470","article-title":"Decoding the ability of Helicobacter pylori to evade immune recognition and cause disease","volume":"19","author":"Is Sirit","year":"2025","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"ref265","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0140-6736(15)60310-5","article-title":"Efficacy, safety, and immunogenicity of an oral recombinant Helicobacter pylori vaccine in children in China: a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"386","author":"Zeng M","year":"2015","journal-title":"Lancet"},{"key":"ref266","article-title":"Advances in Helicobacter pylori vaccine research: From candidate antigens to adjuvants - A review","volume":"28","author":"Yunle K","year":"2023","journal-title":"Helicobacter"},{"key":"ref267","doi-asserted-by":"crossref","first-page":"1432968","DOI":"10.3389\/fimmu.2024.1432968","article-title":"Design of a Helicobacter pylori multi-epitope vaccine based on immunoinformatics","volume":"15","author":"Cui M","year":"2024","journal-title":"Front Immunol"},{"key":"ref268","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3390\/pathogens14070619","article-title":"Challenges and Prospects for Eradication of Helicobacter pylori: Targeting Virulence Factors, Metabolism, and Vaccine Innovation","volume":"14","author":"Bakiera A","year":"2025","journal-title":"Pathogens"},{"key":"ref269","doi-asserted-by":"crossref","first-page":"111441","DOI":"10.1016\/j.compbiomed.2026.111441","article-title":"Unveiling potential Helicobacter pylori vaccine candidates: A comprehensive multi-epitope approach","volume":"202","author":"Souza Guimar\u00e3es AV","year":"2026","journal-title":"Comput Biol Med"},{"key":"ref270","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2147\/CEG.S466975","article-title":"Real-World Situation of Eradication Regimens and Risk Factors for Helicobacter pylori Treatment in China: A Retrospective Single-Center Study","volume":"17","author":"Cheng J","year":"2024","journal-title":"Clin Exp Gastroenterol"},{"issue":"5","key":"ref271","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1053\/j.gastro.2021.07.043","article-title":"Host genetic determinants associated with Helicobacter pylori eradication treatment failure: A systematic review and meta-analysis","volume":"165","author":"Shah SC","year":"2021","journal-title":"Gastroenterology"},{"key":"ref272","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/jac\/dkab415","article-title":"Timing of prior exposure to antibiotics and failure of Helicobacter pylori eradication: a population-based study","volume":"77","author":"Guo CG","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"ref273","article-title":"Effects of prior antibiotic use on clarithromycin resistance in Helicobacter pylori","volume":"28","author":"Kwon YM","year":"2023","journal-title":"Helicobacter"},{"key":"ref274","doi-asserted-by":"crossref","DOI":"10.1086\/510074","article-title":"The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection","volume":"44","author":"Carothers JJ","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref275","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/phar.2318","article-title":"Treatment of Helicobacter pylori in Special Patient Populations","volume":"39","author":"Nguyen CT","year":"2019","journal-title":"Pharmacotherapy"},{"key":"ref276","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/jama.2018.19283","article-title":"Evaluation and Management of Penicillin Allergy: A Review","volume":"321","author":"Shenoy ES","year":"2019","journal-title":"JAMA"},{"key":"ref277","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/17562848241241223","article-title":"P-CAB versus PPI in the eradication of Helicobacter pylori: a systematic review and network meta-analysis","volume":"17","author":"Jiang Y","year":"2024","journal-title":"Ther Adv Gastroenterol"},{"key":"ref278","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.amjmed.2005.10.003","article-title":"Smoking increases the treatment failure for Helicobacter pylori eradication","volume":"119","author":"Suzuki T","year":"2006","journal-title":"Am J Med"},{"key":"ref279","article-title":"Impact of smoking on the eradication of Helicobacter pylori","volume":"27","author":"Yu J","year":"2022","journal-title":"Helicobacter"},{"key":"ref280","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12876-023-03002-z","article-title":"Alcohol increases treatment failure for Helicobacter pylori eradication in Asian populations","volume":"23","author":"Yu J","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"ref281","article-title":"Effects of enhanced education for patients with the Helicobacter pylori infection: A Systematic Review and Meta-Analysis","volume":"27","author":"Zha J","year":"2022","journal-title":"Helicobacter"},{"key":"ref282","article-title":"Application of a social media platform as a patient reminder in the treatment of Helicobacter pylori","volume":"25","author":"Luo M","year":"2020","journal-title":"Helicobacter"},{"key":"ref283","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12569","article-title":"Twice daily short-message-based re-education could improve Helicobacter pylori eradication rate in young population: A prospective randomized controlled study","volume":"24","author":"Wang T","year":"2019","journal-title":"Helicobacter"},{"key":"ref284","doi-asserted-by":"crossref","first-page":"F1000","DOI":"10.12688\/f1000research.8598.1","article-title":"The role of acid inhibition in Helicobacter pylori eradication","volume":"5","author":"Scott DR","year":"2016","journal-title":"F1000Res"},{"key":"ref285","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ueg2.12476","article-title":"Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management","volume":"12","author":"Pab\u00f3n-Carrasco M","year":"2024","journal-title":"United European Gastroenterol J"},{"key":"ref286","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12554","article-title":"Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI","volume":"24","author":"Graham DY","year":"2019","journal-title":"Helicobacter"},{"key":"ref287","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/apt.13588","article-title":"Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype","volume":"43","author":"Kagami T","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref288","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1053\/j.gastro.2022.05.055","article-title":"Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial","volume":"163","author":"Chey WD","year":"2022","journal-title":"Gastroenterology"},{"key":"ref289","article-title":"Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized Trial","author":"Hsu PI","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"ref290","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3748\/wjg.v30.i9.1213","article-title":"Treatment of Helicobacter Pylori With Potassium Competitive Acid Blockers: A Systematic Review and Meta-Analysis","volume":"30","author":"Kanu JE","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"17562848251314801","DOI":"10.1177\/17562848251314801","article-title":"The efficacy and safety of Vonoprazan and Tegoprazan in Helicobacter pylori eradication: a comprehensive systematic review and meta-analysis of randomized controlled trials","volume":"18","author":"Jin T","year":"2025","journal-title":"Ther Adv Gastroenterol"},{"key":"ref292","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1097\/MCG.0000000000002001","article-title":"Vonoprazan Is Not Inferior to Proton Pump Inhibitors in Bismuth-Containing Quadruple Therapy for Helicobacter Pylori Eradication: A Meta-Analysis of 10 Studies From East Asia","volume":"58","author":"Cheng Y","year":"2024","journal-title":"J Clin Gastroenterol"},{"key":"ref293","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13148","article-title":"Efficacy and Safety of Vonoprazan in Dual\/Triple\/Quadruple Regimens Both in First-Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta-Analysis","volume":"29","author":"Benito BM","year":"2024","journal-title":"Helicobacter"},{"key":"ref294","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1093\/jac\/dkae467","article-title":"Vonoprazan improves the efficacy of bismuth quadruple therapy containing doxycycline and metronidazole as first-line Helicobacter pylori treatment in penicillin-allergic patients: a randomized controlled trial","volume":"80","author":"Yan T","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"ref295","article-title":"Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial","volume":"30","author":"Yan TL","year":"2025","journal-title":"Helicobacter"},{"key":"ref296","doi-asserted-by":"crossref","first-page":"S773","DOI":"10.1016\/S0016-5085(25)02733-7","article-title":"Vonoprazan is highly effective and safe as an adjuvant in different regimes in first- and rescue-line therapies for H. pylori infection in Brazil","volume":"169","author":"Chaves SR","year":"2025","journal-title":"Gastroenterology"},{"key":"ref297","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00228-008-0576-5","article-title":"Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH","volume":"65","author":"Kirchheiner J","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"ref298","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/gutjnl-2016-311868","article-title":"First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis","volume":"67","author":"Yeo YH","year":"2018","journal-title":"Gut"},{"key":"ref299","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1136\/gutjnl-2025-335523","article-title":"Helicobacter pylori antibiotic resistance: a global challenge in search of solutions","volume":"74","author":"Schulz C","year":"2025","journal-title":"Gut"},{"key":"ref300","doi-asserted-by":"crossref","first-page":"646","DOI":"10.14309\/ajg.0000000000002600","article-title":"Effectiveness of Helicobacter pylori Treatments According to Antibiotic Resistance","volume":"119","author":"Bujanda L","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"ref301","series-title":"Population-based Helicobacter pylori screen-and-treat strategies","first-page":"338","volume-title":"Considerations for choice of Helicobacter pylori treatment regimens","author":"Gisbert JP","year":"2025"},{"key":"ref302","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/gutjnl-2024-332804","article-title":"Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg)","volume":"74","author":"Olmedo L","year":"2024","journal-title":"Gut"},{"key":"ref303","doi-asserted-by":"crossref","first-page":"913436","DOI":"10.3389\/fmicb.2022.913436","article-title":"Empirical vs. Susceptibility-Guided Treatment of Helicobacter pylori Infection: A Systematic Review and Meta-Analysis","volume":"13","author":"Nyssen OP","year":"2022","journal-title":"Front Microbiol"},{"key":"ref304","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13144","article-title":"Optimal Duration of Bismuth-Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis","volume":"29","author":"Duan M","year":"2024","journal-title":"Helicobacter"},{"key":"ref305","doi-asserted-by":"crossref","first-page":"359","DOI":"10.47892\/rgp.2024.444.1797","article-title":"Actualizaci\u00f3n en el tratamiento de Helicobacter pylori: revisi\u00f3n del LATAMGCHMSG","volume":"44","author":"Otero RW","year":"2024","journal-title":"Rev Gastroenterol Peru"},{"key":"ref306","doi-asserted-by":"crossref","first-page":"17562848221147756","DOI":"10.1177\/17562848221147756","article-title":"High-dose dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori eradication: a systematic review and meta-analysis with trial sequential analysis","volume":"16","author":"Zhou BG","year":"2023","journal-title":"Ther Adv Gastroenterol"},{"key":"ref307","doi-asserted-by":"crossref","first-page":"107331","DOI":"10.1016\/j.ijantimicag.2024.107331","article-title":"Efficacy and safety of vonoprazan and high-dose amoxicillin dual therapy in eradicating Helicobacter pylori: A systematic review and meta-analysis","volume":"64","author":"Zhang J","year":"2024","journal-title":"Int J Antimicrob Agents"},{"key":"ref308","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3390\/microorganisms13040715","article-title":"Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for Helicobacter pylori Infection: A Systematic Review","volume":"13","author":"Shih CA","year":"2025","journal-title":"Microorganisms"},{"key":"ref309","first-page":"345","article-title":"Tailored Helicobacter pylori eradication therapy in obese patients undergoing bariatric surgery","volume":"113","author":"Laudanno O","year":"2021","journal-title":"Rev Esp Enferm Dig"},{"key":"ref310","first-page":"241","article-title":"First-Line Eradication of Helicobacter pylori with High-Dose Dual Therapy Versus Quadruple Therapy with Bismuth for 14 Days: A Multicenter, Prospective and Randomized Study].","volume":"52","author":"Casta\u00f1o Llano R","year":"2022","journal-title":"Acta Gastroenterol Latinoam"},{"key":"ref311","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13052","article-title":"Eradication rate and adherence with high-dose amoxicillin and proton pump inhibitor as first-line treatment for Helicobacter pylori infection: Experience from University Hospital in Chile","volume":"29","author":"von Muhlenbrock C","year":"2024","journal-title":"Helicobacter"},{"key":"ref312","article-title":"A \u201cnew\u201d option in Helicobacter pylori eradication: High-dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting","volume":"28","author":"Macedo Silva V","year":"2023","journal-title":"Helicobacter"},{"key":"ref313","doi-asserted-by":"crossref","first-page":"102768","DOI":"10.1016\/j.jiph.2025.102768","article-title":"The efficacy and safety of vonoprazan-based high-dose dual therapy for eradication of Helicobacter pylori: A systematic review and meta-analysis","volume":"18","author":"Zhang MM","year":"2025","journal-title":"J Infect Public Health"},{"key":"ref314","doi-asserted-by":"crossref","first-page":"437","DOI":"10.14309\/ajg.0000000000000132","article-title":"Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori","volume":"114","author":"Yang J","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"ref315","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.14309\/ajg.0000000000002255","article-title":"Hybrid, High-Dose Dual and Bismuth Quadruple Therapies for First-Line Treatment of Helicobacter pylori Infection in Taiwan: A Multicenter, Open-Label, Randomized Trial","volume":"118","author":"Hsu PI","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"ref316","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/gutjnl-2020-321372","article-title":"European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients","volume":"70","author":"Nyssen OP","year":"2021","journal-title":"Gut"},{"key":"ref317","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cgh.2025.06.029","article-title":"Comparative Effectiveness of Empiric Treatment for Helicobacter pylori in a Large, Diverse Population in the United States","volume":"24","author":"Merchant SA","year":"2026","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref318","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/M19-3734","article-title":"Rifabutin-Based Triple Therapy (RHB-105) for Helicobacter pylori Eradication: A Double-Blind, Randomized, Controlled Trial","volume":"172","author":"Graham DY","year":"2020","journal-title":"Ann Intern Med"},{"key":"ref319","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000002100","article-title":"Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review","volume":"33","author":"De Francesco V","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref320","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/apt.13128","article-title":"Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments","volume":"41","author":"Gisbert JP","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/jgh.14462","article-title":"Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication","volume":"34","author":"Yeo YH","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"ref322","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s40265-017-0730-4","article-title":"Efficacy and Safety of Quinolone-Containing Rescue Therapies After the Failure of Non-Bismuth Quadruple Treatments for Helicobacter pylori Eradication: Systematic Review and Meta-Analysis","volume":"77","author":"Marin AC","year":"2017","journal-title":"Drugs"},{"key":"ref323","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/j.cgh.2021.12.025","article-title":"Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg)","volume":"20","author":"Nyssen OP","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref324","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/apt.13712","article-title":"Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection","volume":"44","author":"Chen PY","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"ref325","series-title":"FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects","year":"2016"},{"key":"ref326","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrgastro.2011.84","article-title":"Helicobacter pylori eradication: A new, single-capsule bismuth-containing quadruple therapy","volume":"8","author":"Gisbert JP","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref327","doi-asserted-by":"crossref","first-page":"59","DOI":"10.7704\/kjhugr.2020.0053","article-title":"Salvage Regimens after Failure of Previous Helicobacter pylori Eradication Therapy: A Systematic Review and meta-analysis","volume":"21","author":"Yang HJ","year":"2021","journal-title":"Korean J Helicobacter Upper Gastrointest Res"},{"key":"ref328","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1007\/s10620-019-05694-4","article-title":"Retrospective Analysis Confirms Tetracycline Quadruple as Best Helicobacter pylori Regimen in the USA","volume":"64","author":"Alsamman MA","year":"2019","journal-title":"Dig Dis Sci"},{"key":"ref329","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12722","article-title":"Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)","volume":"25","author":"Nyssen OP","year":"2020","journal-title":"Helicobacter"},{"key":"ref330","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/infdis\/jiad114","article-title":"Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial","volume":"228","author":"Chen J","year":"2023","journal-title":"J Infect Dis"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/14656566.2021.1982894","article-title":"Evaluating treatments with rifabutin and amoxicillin for eradication of Helicobacter pylori infection in adults: a systematic review","volume":"23","author":"Xirouchakis E","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"ref332","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/jgh.15294","article-title":"Rifabutin triple therapy for first-line and rescue treatment of Helicobacter pylori infection: a systematic review and meta-analysis","volume":"36","author":"Gingold-Belfer R","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"ref333","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3748\/wjg.v29.i2.390","article-title":"Third-line and rescue therapy for refractory Helicobacter pylori infection: A systematic review","volume":"29","author":"De Moraes Andrade PV","year":"2023","journal-title":"World J Gastroenterol"},{"key":"ref334","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12719","article-title":"Efficacy and safety of a new rifabutin-based triple therapy with vonoprazan for refractory Helicobacter pylori infection: A prospective single-arm study","volume":"25","author":"Hirata Y","year":"2020","journal-title":"Helicobacter"},{"key":"ref335","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12830","article-title":"Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections-Exploratory study","volume":"26","author":"Gunaratne AW","year":"2021","journal-title":"Helicobacter"},{"key":"ref336","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/hel.12296","article-title":"Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies","volume":"21","author":"Ciccaglione AF","year":"2016","journal-title":"Helicobacter"},{"key":"ref337","article-title":"Efficacy of Rifabutin-Based Helicobacter pylori Eradication Regimen in Korea With High Prevalence of Tuberculosis Infection","volume":"30","author":"Kim Y","year":"2025","journal-title":"Helicobacter"},{"key":"ref338","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/pathogens10010015","article-title":"Rifabutin for the Treatment of Helicobacter Pylori Infection: A Review","volume":"10","author":"Gisbert JP","year":"2020","journal-title":"Pathogens"},{"key":"ref339","series-title":"Recomenda\u00e7\u00f5es para o diagn\u00f3stico e tratamento de micobact\u00e9rias tuberculosas","year":"2021"},{"key":"ref340","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/MCG.0000000000002100","article-title":"Clinical Impact of High-dose Esomeprazole-amoxicillin Dual Therapy as Rescue Treatment for Helicobacter pylori Infection: A Prospective, Multicenter, Randomized Trial","volume":"59","author":"Wang C","year":"2025","journal-title":"J Clin Gastroenterol"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/jac\/dkad020","article-title":"A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment","volume":"78","author":"Ding ZH","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"ref342","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1046\/j.1523-5378.2003.00158.x","article-title":"A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin","volume":"8","author":"Miehlke S","year":"2003","journal-title":"Helicobacter"},{"key":"ref343","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.3390\/jcm11123544","article-title":"Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg)","volume":"11","author":"Fern\u00e1ndez-Salazar L","year":"2022","journal-title":"J Clin Med"},{"key":"ref344","article-title":"A real-world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy or failed in previous amoxicillin-containing therapies","volume":"28","author":"Gao W","year":"2023","journal-title":"Helicobacter"},{"key":"ref345","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ueg2.70070","article-title":"Efficacy and Safety of Vonoprazan and High-Dose Amoxicillin Dual Therapy for Rescue Treatment of Helicobacter pylori Infection: A Multicenter Randomized Controlled Trial","volume":"13","author":"Zhang J","year":"2025","journal-title":"United European Gastroenterol J"},{"key":"ref346","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/sj.clpt.6100043","article-title":"Pharmacogenomics-based tailored versus standard therapeutic regimen for eradication of H. pylori","volume":"81","author":"Furuta T","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"ref347","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/CMR.00033-06","article-title":"Helicobacter pylori detection and antimicrobial susceptibility testing","volume":"20","author":"M\u00e9graud F","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"ref348","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00284-006-0143-1","article-title":"Antibiotic susceptibility of Helicobacter pylori clinical isolates: comparative evaluation of disk-diffusion and E-test methods","volume":"53","author":"Mishra KK","year":"2006","journal-title":"Curr Microbiol"},{"key":"ref349","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00550-23","article-title":"Phenotype and genotype analysis for Helicobacter pylori antibiotic resistance in outpatients: a retrospective study","volume":"11","author":"Xiong M","year":"2023","journal-title":"Microbiol Spectr"},{"key":"ref350","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.eimc.2016.02.010","article-title":"Antimicrobial susceptibility of 6 antimicrobial agents in Helicobacter pylori clinical isolates by using EUCAST breakpoints compared with previously used breakpoints","volume":"35","author":"Alarc\u00f3n T","year":"2017","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref351","series-title":"Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria","year":"2016","edition":"3rd ed"},{"key":"ref352","doi-asserted-by":"crossref","first-page":"524","DOI":"10.14309\/ajg.0000000000001659","article-title":"Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why","volume":"117","author":"Graham DY","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"ref353","first-page":"22","article-title":"Review: Diagnostic accuracy of PCR-based detection tests for Helicobacter Pylori in stool samples","author":"Khadangi F","year":"2017","journal-title":"Helicobacter"},{"key":"ref354","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13099-017-0198-5","article-title":"Phenotypic and genotypic correlation as expressed in Helicobacter pylori resistance to clarithromycin and fluoroquinolones","volume":"9","author":"Binyamin D","year":"2017","journal-title":"Gut Pathog"},{"key":"ref355","doi-asserted-by":"crossref","first-page":"596371","DOI":"10.3389\/fcimb.2020.596371","article-title":"Comparison of the Diagnostic Performance of qPCR, Sanger Sequencing, and Whole-Genome Sequencing in Determining Clarithromycin and Levofloxacin Resistance in Helicobacter pylori","volume":"10","author":"Egli K","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"ref356","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2024.39.e44","article-title":"Antibiotic Resistance of Helicobacter pylori: Mechanisms and Clinical Implications","volume":"39","author":"Hasanuzzaman M","year":"2024","journal-title":"J Korean Med Sci"},{"key":"ref357","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.gtc.2015.05.003","article-title":"How to Effectively Use Bismuth Quadruple Therapy: The Good, the Bad, and the Ugly","volume":"44","author":"Graham DY","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"ref358","doi-asserted-by":"crossref","first-page":"1756284820968736","DOI":"10.1177\/1756284820968736","article-title":"Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review","volume":"13","author":"Gisbert JP","year":"2020","journal-title":"Ther Adv Gastroenterol"},{"key":"ref359","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1365-2036.2012.05083.x","article-title":"Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered?","volume":"35","author":"McNulty CA","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref360","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.cgh.2010.05.006","article-title":"Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial","volume":"8","author":"Cammarota G","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"101832","DOI":"10.1016\/j.clinre.2021.101832","article-title":"The efficacy of adjuvant N acetyl cysteine for the eradication of H pylori infections: A systematic review and meta-analysis of randomized clinical trials","volume":"46","author":"Biswas DP","year":"2022","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref362","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gutjnl-2015-311019","article-title":"Role of bismuth in improving Helicobacter pylori eradication with triple therapy","volume":"65","author":"Dore MP","year":"2016","journal-title":"Gut"},{"key":"ref363","doi-asserted-by":"crossref","first-page":"106429","DOI":"10.1016\/j.jinf.2025.106429","article-title":"The global prevalence of reported penicillin allergy: A systematic review and meta-analysis","volume":"90","author":"Luintel A","year":"2025","journal-title":"J Infect"},{"key":"ref364","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jaci.2020.04.058","article-title":"Accuracy of penicillin allergy diagnostic tests: A systematic review and meta-analysis","volume":"147","author":"Sousa-Pinto B","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"ref365","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1016\/j.jaip.2023.09.045","article-title":"Penicillin Allergy Evaluation Should Be Performed Proactively in Patients With a Penicillin Allergy Label","volume":"11","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref366","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/antibiotics14050476","article-title":"Clinical Effectiveness of Penicillin-Free Therapies in First-Line and Rescue Treatments for Helicobacter pylori: A Systematic Review","volume":"14","author":"El Boury K","year":"2025","journal-title":"Antibiotics"},{"key":"ref367","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.3748\/wjg.v27.i44.7661","article-title":"Treatment of Helicobacter pylori infection in the presence of penicillin allergy","volume":"27","author":"Dutta AK","year":"2021","journal-title":"World J Gastroenterol"},{"key":"ref368","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/antibiotics12040737","article-title":"Treatment of Helicobacter pylori infection in patients with Penicillin Allergy","volume":"12","author":"Liu L","year":"2023","journal-title":"Antibiotics"},{"key":"ref369","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1136\/gutjnl-2024-332640","article-title":"Simplified Helicobacter pylori therapy for patients with penicillin allergy: a randomised controlled trial of vonoprazan-tetracycline dual therapy","volume":"73","author":"Gao W","year":"2024","journal-title":"Gut"},{"key":"ref370","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s10620-014-3365-2","article-title":"Helicobacter Pylori First-Line and Rescue Treatments in the Presence of Penicillin Allergy","volume":"60","author":"Gisbert JP","year":"2015","journal-title":"Dig Dis Sci"},{"key":"ref371","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12686","article-title":"Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)","volume":"25","author":"Nyssen OP","year":"2020","journal-title":"Helicobacter"},{"key":"ref372","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70033","article-title":"Efficacy and Safety of Cefuroxime-Tetracycline-Containing Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Penicillin-Allergic Patients: A Multicenter Randomized Controlled Trial","volume":"30","author":"Wang H","year":"2025","journal-title":"Helicobacter"},{"key":"ref373","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/jcm11061658","article-title":"Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg)","volume":"11","author":"Nyssen OP","year":"2022","journal-title":"J Clin Med"},{"key":"ref374","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3390\/microorganisms12101986","article-title":"Opportunities for Helicobacter pylori Eradication beyond Conventional Antibiotics","volume":"12","author":"Savitri CMA","year":"2024","journal-title":"Microorganisms"},{"key":"ref375","doi-asserted-by":"crossref","first-page":"10644","DOI":"10.3748\/wjg.v21.i37.10644","article-title":"Are probiotics useful in Helicobacter pylori eradication?","volume":"21","author":"Homan M","year":"2015","journal-title":"World J Gastroenterol"},{"key":"ref376","doi-asserted-by":"crossref","first-page":"1620870","DOI":"10.3389\/fphar.2025.1620870","article-title":"Beyond antibiotics: probiotics as a promising ally against Helicobacter pylori","volume":"16","author":"Yuan L","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref377","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3748\/wjg.v24.i1.139","article-title":"Probiotic monotherapy and Helicobacter pylori eradication: A systematic review with pooled-data analysis","volume":"24","author":"Losurdo G","year":"2018","journal-title":"World J Gastroenterol"},{"key":"ref378","doi-asserted-by":"crossref","first-page":"10069","DOI":"10.1038\/s41598-024-59399-4","article-title":"The effects of probiotics supplementation on Helicobacter pylori standard treatment: an umbrella review of systematic reviews with meta-analyses","volume":"14","author":"Yang Z","year":"2024","journal-title":"Sci Rep"},{"key":"ref379","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.clnesp.2024.11.016","article-title":"Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials","volume":"65","author":"Tanashat M","year":"2025","journal-title":"Clin Nutr ESPEN"},{"key":"ref380","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.14309\/ajg.0000000000003351","article-title":"Probiotics Prescribed With Helicobacter pylori Eradication Therapy in Europe: Usage Pattern, Effectiveness, and Safety. Results From the European Registry on Helicobacter pylori Management (Hp-EuReg)","volume":"120","author":"Casas Deza D","year":"2025","journal-title":"Am J Gastroenterol"},{"key":"ref381","doi-asserted-by":"crossref","DOI":"10.1111\/hel.70006","article-title":"Efficacy of Lactobacillus spp. Supplementation in Helicobacter pylori Eradication: A Systematic Meta-Analysis of Randomized Controlled Trials With Trial Sequential Analysis","volume":"29","author":"Mishra V","year":"2024","journal-title":"Helicobacter"},{"key":"ref382","doi-asserted-by":"crossref","first-page":"1441185","DOI":"10.3389\/fcimb.2025.1441185","article-title":"Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis","volume":"15","author":"Li M","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref383","first-page":"8B","article-title":"The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk","volume":"17","author":"Troost E","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"ref384","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1136\/gutjnl-2024-332815","article-title":"Stomach microbiota in gastric cancer development and clinical implications","volume":"73","author":"Zeng R","year":"2024","journal-title":"Gut"},{"key":"ref385","first-page":"3382","article-title":"Influence of Helicobacter pylori infection and its eradication treatment on small intestinal bacterial overgrowth","volume":"102","author":"Zhu D","year":"2022","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"ref386","doi-asserted-by":"crossref","first-page":"12874","DOI":"10.1038\/s41598-019-49415-3","article-title":"Effects of anti-H. pylori triple therapy and a probiotic complex on intestinal microbiota in duodenal ulcer","volume":"9","author":"Wu L","year":"2019","journal-title":"Sci Rep"},{"key":"ref387","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1473-3099(19)30272-5","article-title":"Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial","volume":"19","author":"Liou JM","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"ref388","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000527047","article-title":"Effects of Helicobacter pylori Therapy on Gut Microbiota: A Systematic Review and Meta-Analysis","volume":"42","author":"Du L","year":"2024","journal-title":"Dig Dis"},{"key":"ref389","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009836","article-title":"Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome","volume":"5","author":"Jakobsson HE","year":"2010","journal-title":"PLoS One"},{"key":"ref390","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2025.1592977","article-title":"The impact of Helicobacter infection and eradication therapies on gut microbiota: a systematic review of microbial dysbiosis and its implications on gastric carcinogenisis","volume":"15","author":"Albush A","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/s41467-023-37975-y","article-title":"Altered human gut virome in patients undergoing antibiotics therapy for Helicobacter pylori","volume":"14","author":"Wang L","year":"2023","journal-title":"Nat Commun"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":["V Consenso Brasileiro sobrea infec\u00e7\u00e3o por Helicobacter pylori"],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0004-28032026000106602&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T12:47:24Z","timestamp":1786366044000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032026000106602&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":391,"alternative-id":["S0004-28032026000106602"],"URL":"https:\/\/doi.org\/10.1590\/s0004-2803.24612026-043","relation":{},"ISSN":["1678-4219","0004-2803"],"issn-type":[{"value":"1678-4219","type":"electronic"},{"value":"0004-2803","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e26043"}}